{
    "2018-10-08": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Analyst Pick",
                        "Dow"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Novartis' Applications for MS Drug Accepted by FDA & EMA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "MS Drug",
                        "FDA",
                        "EMA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Novan scores $11M with partnership with Japanese pharma",
                "features": {
                    "keywords": [
                        "Novan",
                        "partnership",
                        "Japanese pharma"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Novartis Applications for MS Drug Accepted by FDA & EMA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "MS Drug",
                        "FDA",
                        "EMA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan",
                "features": {
                    "keywords": [
                        "Novan",
                        "Nitric Oxide",
                        "Dermatology",
                        "Sato",
                        "Japan"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-25",
                "original_text": "Novartis Announces FDA And EMA Filing Acceptance Of Siponimod",
                "features": {
                    "keywords": [
                        "Novartis",
                        "FDA",
                        "EMA",
                        "Siponimod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}